137 related articles for article (PubMed ID: 30287226)
1. A standardized approach to the evaluation of antivirals against DNA viruses: Orthopox-, adeno-, and herpesviruses.
Hartline CB; Keith KA; Eagar J; Harden EA; Bowlin TL; Prichard MN
Antiviral Res; 2018 Nov; 159():104-112. PubMed ID: 30287226
[TBL] [Abstract][Full Text] [Related]
2. A standardized approach to the evaluation of antivirals against DNA viruses: Polyomaviruses and lymphotropic herpesviruses.
Keith KA; Hartline CB; Bowlin TL; Prichard MN
Antiviral Res; 2018 Nov; 159():122-129. PubMed ID: 30287227
[TBL] [Abstract][Full Text] [Related]
3. ASP2151, a novel helicase-primase inhibitor, possesses antiviral activity against varicella-zoster virus and herpes simplex virus types 1 and 2.
Chono K; Katsumata K; Kontani T; Kobayashi M; Sudo K; Yokota T; Konno K; Shimizu Y; Suzuki H
J Antimicrob Chemother; 2010 Aug; 65(8):1733-41. PubMed ID: 20534624
[TBL] [Abstract][Full Text] [Related]
4. Susceptibilities of human cytomegalovirus clinical isolates and other herpesviruses to new acetylated, tetrahalogenated benzimidazole D-ribonucleosides.
Hwang JS; Schilf R; Drach JC; Townsend LB; Bogner E
Antimicrob Agents Chemother; 2009 Dec; 53(12):5095-101. PubMed ID: 19786605
[TBL] [Abstract][Full Text] [Related]
5. The antiviral spectrum of Listerine antiseptic.
Dennison DK; Meredith GM; Shillitoe EJ; Caffesse RG
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 1995 Apr; 79(4):442-8. PubMed ID: 7614202
[TBL] [Abstract][Full Text] [Related]
6. Comparison of a DNA probe assay with the plaque reduction assay for measuring the sensitivity of herpes simplex virus and varicella-zoster virus to penciclovir and acyclovir.
Standring-Cox R; Bacon TH; Howard BA
J Virol Methods; 1996 Jan; 56(1):3-11. PubMed ID: 8690764
[TBL] [Abstract][Full Text] [Related]
7. In vitro activities of benzimidazole D- and L-ribonucleosides against herpesviruses.
Williams SL; Hartline CB; Kushner NL; Harden EA; Bidanset DJ; Drach JC; Townsend LB; Underwood MR; Biron KK; Kern ER
Antimicrob Agents Chemother; 2003 Jul; 47(7):2186-92. PubMed ID: 12821466
[TBL] [Abstract][Full Text] [Related]
8. H84T BanLec has broad spectrum antiviral activity against human herpesviruses in cells, skin, and mice.
Lloyd MG; Liu D; Legendre M; Markovitz DM; Moffat JF
Sci Rep; 2022 Jan; 12(1):1641. PubMed ID: 35102178
[TBL] [Abstract][Full Text] [Related]
9. Development of CMX001 (Brincidofovir) for the treatment of serious diseases or conditions caused by dsDNA viruses.
Florescu DF; Keck MA
Expert Rev Anti Infect Ther; 2014 Oct; 12(10):1171-8. PubMed ID: 25120093
[TBL] [Abstract][Full Text] [Related]
10. Preliminary Screening and In Vitro Confirmation of Orthopoxvirus Antivirals.
Grosenbach DW; Hruby DE
Methods Mol Biol; 2019; 2023():143-155. PubMed ID: 31240676
[TBL] [Abstract][Full Text] [Related]
11. A rapid assay for evaluation of antiviral activity against coxsackie virus B3, influenza virus A, and herpes simplex virus type 1.
Schmidtke M; Schnittler U; Jahn B; Dahse H; Stelzner A
J Virol Methods; 2001 Jun; 95(1-2):133-43. PubMed ID: 11377720
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and antiviral activities of methylenecyclopropane analogs with 6-alkoxy and 6-alkylthio substitutions that exhibit broad-spectrum antiviral activity against human herpesviruses.
Prichard MN; Williams JD; Komazin-Meredith G; Khan AR; Price NB; Jefferson GM; Harden EA; Hartline CB; Peet NP; Bowlin TL
Antimicrob Agents Chemother; 2013 Aug; 57(8):3518-27. PubMed ID: 23669381
[TBL] [Abstract][Full Text] [Related]
13. Inhibitors of nucleotidyltransferase superfamily enzymes suppress herpes simplex virus replication.
Tavis JE; Wang H; Tollefson AE; Ying B; Korom M; Cheng X; Cao F; Davis KL; Wold WS; Morrison LA
Antimicrob Agents Chemother; 2014 Dec; 58(12):7451-61. PubMed ID: 25267681
[TBL] [Abstract][Full Text] [Related]
14. 4-Oxo-4,7-dihydrothieno[2,3-b]pyridines as non-nucleoside inhibitors of human cytomegalovirus and related herpesvirus polymerases.
Schnute ME; Cudahy MM; Brideau RJ; Homa FL; Hopkins TA; Knechtel ML; Oien NL; Pitts TW; Poorman RA; Wathen MW; Wieber JL
J Med Chem; 2005 Sep; 48(18):5794-804. PubMed ID: 16134946
[TBL] [Abstract][Full Text] [Related]
15. Amino acid changes within conserved region III of the herpes simplex virus and human cytomegalovirus DNA polymerases confer resistance to 4-oxo-dihydroquinolines, a novel class of herpesvirus antiviral agents.
Thomsen DR; Oien NL; Hopkins TA; Knechtel ML; Brideau RJ; Wathen MW; Homa FL
J Virol; 2003 Feb; 77(3):1868-76. PubMed ID: 12525621
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and Ativiral Activity of 5-(Benzylthio)-4-carbamyl-1,2,3-triazoles Against Human Cytomegalovirus (CMV) and Varicella-zoster Virus (VZV).
Wen YN; Zhang ZF; Liu NN; Andrei G; Snoeck R; Xiang YH; Schols D; Chen X; Zhang ZY; Zhang QS; Wu QP
Med Chem; 2017; 13(5):453-464. PubMed ID: 28290250
[TBL] [Abstract][Full Text] [Related]
17. Fluorescence-based antiviral assay for the evaluation of compounds against vaccinia virus, varicella zoster virus and human cytomegalovirus.
Dal Pozzo F; Andrei G; Daelemans D; Winkler M; Piette J; De Clercq E; Snoeck R
J Virol Methods; 2008 Jul; 151(1):66-73. PubMed ID: 18490063
[TBL] [Abstract][Full Text] [Related]
18. Herpesviridae and novel inhibitors.
Siakallis G; Spandidos DA; Sourvinos G
Antivir Ther; 2009; 14(8):1051-64. PubMed ID: 20032535
[TBL] [Abstract][Full Text] [Related]
19. Synergistic antiviral activity of acyclovir and vidarabine against herpes simplex virus types 1 and 2 and varicella-zoster virus.
Suzuki M; Okuda T; Shiraki K
Antiviral Res; 2006 Nov; 72(2):157-61. PubMed ID: 16797734
[TBL] [Abstract][Full Text] [Related]
20. Antiherpesvirus activities of two novel 4'-thiothymidine derivatives, KAY-2-41 and KAH-39-149, are dependent on viral and cellular thymidine kinases.
Coen N; Duraffour S; Haraguchi K; Balzarini J; van den Oord JJ; Snoeck R; Andrei G
Antimicrob Agents Chemother; 2014 Aug; 58(8):4328-40. PubMed ID: 24820089
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
